A prospective study of nutritional status in immunoglobulin light chain amyloidosis

Haematologica

Volumn 98, Issue 1, 2013, Pages 136-140

  Sattianayagam, Prayman T ^a   Lane, Thirusha ^a   Fox, Zoe ^b   Petrie, Aviva ^c   Gibbs, Simon D J ^a   Pinney, Jennifer H ^a   Risom, Signe S ^a   Rowczenio, Dorota M ^a   Wechalekar, Ashutosh D ^a   Lachmann, Helen J ^a   Gilbertson, Janet A ^a   Hawkins, Philip N ^a   Gillmore, Julian D ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Division of Medicine   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; AUTONOMIC NEUROPATHY; BODY MASS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; NUTRITIONAL STATUS; OBSERVATIONAL STUDY; PATIENT GENERATED SUBJECTIVE GLOBAL ASSESSMENT SCORE; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RISK; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PROSPECTIVE STUDIES;

EID: 84872069528     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2012.070359     Document Type: Article

References (24)

1. Pepys MB. Amyloidosis. Annu Rev Med. 2006;57:223-41.
2. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995;32(1):45-59.
3. Merlini G, Palladini G. Amyloidosis: is a cure possible? Ann Oncol. 2008;19(Suppl 4).
4. Dispenzieri A, Lacy MQ, Kyle RA, Therneau TM, Larson DR, Rajkumar SV, et al. Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival. J Clin Oncol. 2001;19(14):3350-6.
5. Caccialanza R, Palladini G, Klersy C, Cena H, Vagia C, Cameletti B, et al. Nutritional status of outpatients with systemic immunoglobulin light-chain amyloidosis 1. Am J Clin Nutr. 2006;83(2):350-4.
6. Caccialanza R, Palladini G, Klersy C, Cereda E, Bonardi C, Cameletti B, et al. Nutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosis. Ann Hematol. 2012;91(3):399-406.
7. Gupta D, Lis CG, Granick J, Grutsch JF, Vashi PG, Lammersfeld CA. Malnutrition was associated with poor quality of life in colorectal cancer: a retrospective analysis. J Clin Epidemiol. 2006;59(7):704-9.
8. Hammerlid E, Wirblad B, Sandin C, Mercke C, Edstrom S, Kaasa S, et al. Malnutrition and food intake in relation to quality of life in head and neck cancer patients. Head Neck. 1998;20(6):540-8.
9. Seldin DC, Anderson JJ, Sanchorawala V, Malek K, Wright DG, Quillen K, et al. Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation. Blood. 2004;104(6):1888-93.
10. Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, et al. Definition of organ involvement and treatment response in primary systemic amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Haematol. 2005;79 (4):319-28.
11. Dispenzieri A, Gertz M, Kyle R, Lacy M, Burritt MF, Therneau TM, et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol. 2004;22(18):3751-7.
12. Ottery FD. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition. 1996: S15-S9.
13. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365-76.
14. Fayers P, Bottomley A. Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer. 2002;38 (Suppl 4):S125-33.
15. Gillmore JD, Cocks K, Gibbs SDJ, Sattianayagam P, Lane T, Lachmann HJ, et al. UK AL Amyloidosis Treatment Trial (UKATT)-a randomised study: lessons for future trial design. Amyloid-Journal of Protein Folding Disorders. 2010;17:88-9.
16. Bauer J, Capra S, Ferguson M. Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr. 2002;56(8):779-85.
17. Park MA, Mueller PS, Kyle RA, Larson DR, Plevak MF, Gertz MA. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients. Medicine. (Baltimore) 2003;82(5):291-8.
18. Kalantar-Zadeh K, Anker SD, Horwich TB, Fonarow GC. Nutritional and anti-inflammatory interventions in chronic heart failure. Am J Cardiol. 2008;101(11A):89E-103E.
19. Ovesen L, Hannibal J, Mortensen EL. The interrelationship of weight loss, dietary intake, and quality of life in ambulatory patients with cancer of the lung, breast, and ovary. Nutr Cancer. 1993;19(2):159-67.
20. Lim HJ, Choue R. Nutritional status assessed by the Patient-Generated Subjective Global Assessment (PG-SGA) is associated with qualities of diet and life in Korean cerebral infarction patients. Nutrition. 2010;26(7-8):766-71.
21. Persson C, Sjoden PO, Glimelius B. The Swedish version of the patient-generated subjective global assessment of nutritional status: gastrointestinal vs urological cancers. Clin Nutr. 1999;18(2):71-7.
22. Fiaccadori E, LombardiM, Leonardi S, Rotelli CF, Tortorella G, Borghetti A. Prevalence and clinical outcome associated with preexisting malnutrition in acute renal failure: a prospective cohort study. J Am Soc Nephrol. 1999;10(3):581-93.
23. Dingli D, Tan TS, Kumar SK, Buadi FK, Dispenzieri A, Hayman SR, et al. Stem cell transplantation in patients with autonomic neuropathy due to primary (AL) amyloidosis. Neurology. 2010;74(11):913-8.
24. Lovat LB, Persey MR, Madhoo S, Pepys MB, Hawkins PN. The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients. Gut. 1998;42(5):727-34.